Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2018

Jun 12, 2018

32414_dirs_2018-06-12_a0cf43c9-8313-46bd-ba12-43232b93175f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-09-08

Reporting Person: Rudelius Robert James (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-08 Common Stock M 12000 $2.75 Acquired 35273 Direct
2018-06-08 Common Stock F 682 $48.40 Disposed 34591 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-06-08 Director Stock Option (right to purchase) $2.75 M 12000 Disposed 2018-10-10 Common Stock (12000) Direct

Footnotes

F1: This Form is being filed to report the exercise of a stock option for a total of 12,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 11,318 shares of common stock.